ClinicalTrials.gov
public full text
Public Domain
Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors
colorectal-cancerendometrial-cancerhead-and-neck-cancerliver-cancerlung-cancermelanoma-skinpancreatic-cancerprotocol-specific
RATIONALE: Vaccines made from a peptide may make the body build an immune response to kill tumor cells. Combining vaccine therapy with interleukin-2 and/or sargramostim may be a more effective treatment for solid tumors. PURPOSE: Phase II trial to study the effectiveness of vaccine therapy plus interleukin-2 and/or sargramostim in treating adults who have metastatic solid tumors.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Vaccine Therapy With or Without Sargramostim in Treating Patients With Cancer#651120
- Pilot Study of Neoantigen Peptides and Leukine for the Treatment of Neoplasms#1245890
- Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer#407764
- Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer#256864
- Vaccine Therapy in Treating Patients With Metastatic Cancer#125943
Record · ID 1396427
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive